IRVING, Texas--(BUSINESS WIRE)--Delivering testosterone via bioabsorbable pellets inserted under the skin is a low-risk approach to long-term hormone therapy for women and men, according to ...

Biote CEO Terry Weber moved to Dallas from Orange County, Calif., in 2018 to lead the hormone replacement therapy provider into its next stage of growth. The Irving-based company is expecting up to ...

BEAUMONT, Texas — One Beaumont woman is thanking a tiny pellet filled with testosterone for turning her life around. For most of her life, Virginia Coleman struggled with a hormone imbalance, and she ...

On Thursday, Jefferies, a global investment banking firm, initiated coverage on Biote Corp. (NASDAQ:BTMD), a hormone optimization provider, with a Buy rating and a price target of $6.55. The company, ...

The company, which generates revenue through pellet procedures, has a significant potential market of 55 million but currently has low brand awareness, with approximately 400,000 patients and around 7 ...